Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Listerine Total Care Antiseptic Mouthwash, Clean Mint Flavour
Active Ingredients: Benzoic acid 0.12%w/v
Cineole 0.092%w/v
Ethanol 18.096%w/v
Sodium fluoride 0.0221%w/v
Thymol 0.064%w/v
Zinc chloride 0.09%w/v
Dosage Form: Mouthwash
New Zealand Sponsor: Johnson & Johnson (New Zealand) Limited
Manufacturer: IDS Manufacturing Limited, Pathumthani, Thailand
Product: Tasigna
Active Ingredient: Nilotinib hydrochloride monohydrate 165.45mg equivalent to nilotinib anhydrous free base 150mg
Dosage Form: Capsule
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Product: Your Pharmacy Double Strength Paracetamol Suspension
Active Ingredient: Paracetamol 4.167%w/w
Dosage Form: Oral suspension
New Zealand Sponsor: Orion Laboratories (NZ) Limited
Manufacturer: PSM Healthcare Limited trading as API Consumer Brands, Auckland, New Zealand
Product: Your Pharmacy Pain Relief
Active Ingredients: Codeine phosphate hemihydrate 10mg
Paracetamol 500mg
Dosage Form: Tablet
New Zealand Sponsor: Orion Laboratories (NZ) Limited
Manufacturer: PSM Healthcare Limited trading as API Consumer Brands, Auckland, New Zealand
Dated this 7th day of April 2011.
MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).